InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
1.330
-0.020 (-1.48%)
Oct 2, 2026, 4:00 PM EDT - Market closed
InMed Pharmaceuticals Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
6
Market Cap
8.84M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | - | - | - |
| Jun 30, 2025 | - | - | - |
| Jun 30, 2024 | 4.60M | 462.17K | 11.18% |
| Jun 30, 2023 | 4.14M | 3.05M | 279.61% |
| Jun 30, 2022 | 1.09M | - | - |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Aytu BioPharma | 57.57M |
| Biofrontera | 46.18M |
| IM Cannabis | 32.25M |
| Sonoma Pharmaceuticals | 21.92M |
| cbdMD | 20.93M |
| TherapeuticsMD | 3.27M |
| Gelteq | 314.70K |
| PRF Technologies | 31.00K |
INM News
- 14 days ago - InMed receives Nasdaq notification from listing qualifications department - TheFly
- 14 days ago - InMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Shareholders' Equity Compliance - Newsfile Corp
- 23 days ago - InMed Reports Full Year Fiscal 2026 Financial Results and Provides Corporate Update - Newsfile Corp
- 24 days ago - InMed Pharmaceuticals Annual report: Q4 2026 - Filings
- 24 days ago - InMed Pharmaceuticals Earnings release: Q4 2026 - Filings
- 2 months ago - Mentari Therapeutics Announces $200 Million Private Placement for Migraine Prevention Pipeline - PRNewsWire
- 2 months ago - InMed Pharmaceuticals amends merger pact with Mentari Therapeutics - TheFly
- 2 months ago - InMed Pharmaceuticals and Mentari Therapeutics Announce Amendment to Merger Agreement and Filing of Registration Statement on Form S-4 - Newsfile Corp